PX
56
3
ROK
46
3
CAH
44
7
TXN
29
4
HD
43
8
M
40
3
DD
44
2
APA
30
5
MDT
59
4
EOG
28
2
INTU
54
2
CCI
30
2
WAT
55
11
BEN
36
4
AZO
46
3
LEN
21
3
HST
53
4
CAT
47
3
PPL
44
9
BAC
38
3
PX
56
3
ROK
46
3
CAH
44
7
TXN
29
4
HD
43
8
M
40
3
DD
44
2
APA
30
5
MDT
59
4
EOG
28
2
INTU
54
2
CCI
30
2
WAT
55
11
BEN
36
4
AZO
46
3
LEN
21
3
HST
53
4
CAT
47
3
PPL
44
9
BAC
38
3
Financhill
Back

Roivant Sciences Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

ROIV
Roivant Sciences

Last Price:
$11.58
Seasonality Move:
-15.05%

7 Day Trial

ALL ACCESS PASS

$ 7

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.

Roivant Sciences Price Quote

$11.58
+0.01 (+0.7%)
(Updated: December 21, 2024 at 5:45 AM ET)

Roivant Sciences Key Stats

Sell
44
Roivant Sciences (ROIV) is a Sell
Day range:
$11.41 - $11.67
52-week range:
$9.69 - $13.06
Dividend yield:
0%
P/E ratio:
2.21
P/S ratio:
73.94
P/B ratio:
1.63%
Volume:
14.1M
Avg. volume:
5.5M
1-year change:
16.16%
Market cap:
$8.4B
Revenue:
$124.8M
EPS:
$5.65

How Much Does Roivant Sciences Make?

Data Unavailable

Is Roivant Sciences Growing As A Company?

Data Unavailable

Roivant Sciences Stock Price Performance

  • Did Roivant Sciences Stock Go Up Last Month?
    Roivant Sciences share price went up by 0.7% last month
  • Did ROIV's Share Price Rise Over The Last Year?
    ROIV share price rose by 16.16% over the past 1 year

What Is Roivant Sciences 52-Week High & Low?

Roivant Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Roivant Sciences?

Data Unavailable

Is Roivant Sciences Cash Flow Positive?

Data Unavailable

Roivant Sciences Return On Invested Capital

Data Unavailable

Roivant Sciences Earnings Date & Stock Price

Roivant Sciences Competitors

  • Who Are Roivant Sciences's Competitors?
    Below is a list of companies who compete with Roivant Sciences or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • AstraZeneca PLC (AZN)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • Centessa Pharmaceuticals PLC (CNTA)
    • Verona Pharma PLC (VRNA)

Roivant Sciences Dividend Yield

Data Unavailable

Roivant Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -56.32%
Revenue: 22.67% -43.14%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable